Sign in

CIK 0001321834

  • Non-accelerated filer
  • Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 4 Grant or award VP - Finance, Treasurer acquired 36,277 shares (grant or award)
  2. 4 Gift Chief Executive Officer gave 150,000 shares (gift)
  3. 5 Insider Annual Insider Trading Report
  4. 4 Gift Chief Executive Officer gave 27,500 shares (gift)
  5. 4 Open-market buy Chief Executive Officer bought 2,500 shares at an average $2.23 ($5,567)
  6. 4 Open-market buy Executive Chairman, Secretary bought 2,100 shares at $1.34 ($2,814)
  7. 4/A Grant or award Director acquired 50,000 shares (grant or award)
  8. 4 Grant or award Director acquired 70,000 shares (grant or award)
  9. 4 Grant or award Director acquired 55,000 shares (grant or award)
  10. 4 Grant or award VP - Finance, Treasurer acquired 22,500 shares (grant or award)
  11. 4 Grant or award Director acquired 48,125 shares (grant or award)
  12. 4 Grant or award Director acquired 32,083 shares (grant or award)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market buy VP - Finance, Treasurer bought 3,500 shares at $1.50 ($5,250)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 35,000 shares (grant or award)
  18. 4 Grant or award Executive Chairman, Secretary acquired 70,000 shares (grant or award)
  19. 4 Grant or award Director acquired 50,000 shares (grant or award)
  20. 4 Grant or award Director acquired 35,000 shares (grant or award)

Page 6 of 7 · 132 filings